SCHEMBL10143360

SCHEMBL10143360

Cc1nc2c(-c3ccc[nH]c3=O)c(C(=O)O)n(Cc3cc4ccccc4nc3Cl)c2cc1F

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C8 P10632 1/20 0.79
KMT2A Q03164 10/20 0.43
MEN1 O00255 3/20 0.38
RCE1 Q9Y256 1/20 0.38
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
FAAH O00519 1/20 0.35
CYP1A2 P05177 1/20 0.35
HPGD P15428 1/20 0.35
GAA P10253 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13926196 0.94 CYP2C8 (0.69) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL14802313 0.90 CYP2C8 (0.65) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL10143268 0.90 CYP2C8 (0.64) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL10143822 0.89 CYP2C8 (0.63) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL12665480 0.88 CYP2C8 (1.00) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL14802274 0.88 CYP2C8 (0.61) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL12665493 0.86 CYP2C8 (0.85) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL12665585 0.85 CYP2C8 (0.89) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL14802276 0.85 CYP2C8 (0.59) CYP2C8KMT2AMEN1RCE1KDM4E
SCHEMBL13906259 0.85 CYP2C8 (0.79) CYP2C8KMT2AMEN1RCE1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404845-B2 2,3-substituted azaindole derivatives for treating viral infections MERCK SHARP & DOHME CORP. (US) 2013-03-26 US disclosed
US-8404845-B2 2,3-substituted azaindole derivatives for treating viral infections MERCK SHARP & DOHME CORP. (US) 2013-03-26 US disclosed
EP-2195317-B1 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS SCHERING CORP (US) 2012-01-18 EP disclosed
WO-2009032125-A1 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2009-03-12 WO disclosed